ACC.26 advanced registration ends Feb. 12 – register now!

Frans J. J. Van de Werf, MD, FACC

General Statement of Disclosure:

RESEARCH/RESEARCH GRANTS: Boehringer Ingelheim Pharmaceuticals, Inc(NONE)

View Full Disclosure